htrf-research-on-neutralizing-antibodies-in-ai-diseases
Application Note

Research on neutralizing antibodies in autoimmune diseases

Identifying potent biotherapeutics to address autoimmune diseases with an HTRF approach

Autoimmune diseases are associated with uncontrolled production of inflammatory cytokines that attack different parts of the body. Neutralizing monoclonal antibodies can be used to counter this phenomenon by disrupting intracellular signaling pathways. HTRF technology is effective for studying neutralizing antibodies and analyzing various parameters.

Get your application note now to:

  • Review TNFα and IL6 pathways
  • Discover the successful application of HTRF for studying anti-IL6R and anti-TNFα antibodies
  • See detailed experimental conditions and explanatory diagrams

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Research on neutralizing antibodies in autoimmune diseases

Download Application Note